Hypertension as cardiovascular risk factor in chronic kidney disease

M Burnier, A Damianaki - Circulation research, 2023 - Am Heart Assoc
Hypertension is the leading modifiable cause of premature death and hence one of the
global targets of World Health Organization for prevention. Hypertension also affects the …

Evaluation of the accuracy of cuffless blood pressure measurement devices: challenges and proposals

R Mukkamala, M Yavarimanesh, K Natarajan… - …, 2021 - Am Heart Assoc
Several novel cuffless wearable devices and smartphone applications claiming that they can
measure blood pressure (BP) are appearing on the market. These technologies are very …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Metabolic syndrome—A new definition and management guidelines

P Dobrowolski, A Prejbisz, A Kuryłowicz… - Arterial …, 2022 - journals.viamedica.pl
The joint position paper by Polish Society of Hypertension, Polish Society for the Treatment
of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of …

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022

American Diabetes Association Professional … - Diabetes …, 2022 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …

Toward precision medicine: circadian rhythm of blood pressure and chronotherapy for hypertension-2021 NHLBI workshop report

ML Gumz, D Shimbo, M Abdalla, RC Balijepalli… - …, 2023 - Am Heart Assoc
Healthy individuals exhibit blood pressure variation over a 24-hour period with higher blood
pressure during wakefulness and lower blood pressure during sleep. Loss or disruption of …

How to improve awareness, treatment, and control of hypertension in Africa, and how to reduce its consequences: a call to action from the World Hypertension League

G Parati, DT Lackland, NRC Campbell… - …, 2022 - Am Heart Assoc
Hypertension is the leading preventable risk factor for cardiovascular diseases and disability
globally. In low-and middle-income countries hypertension has a major social impact …

Clinical trial design principles and outcomes definitions for device-based therapies for hypertension: a consensus document from the hypertension academic research …

DE Kandzari, F Mahfoud, MA Weber, R Townsend… - Circulation, 2022 - Am Heart Assoc
The clinical implications of hypertension in addition to a high prevalence of both
uncontrolled blood pressure and medication nonadherence promote interest in developing …

Effects of renal denervation vs sham in resistant hypertension after medication escalation: prespecified analysis at 6 months of the RADIANCE-HTN TRIO randomized …

M Azizi, F Mahfoud, MA Weber, ASP Sharp… - JAMA …, 2022 - jamanetwork.com
Importance Although early trials of endovascular renal denervation (RDN) for patients with
resistant hypertension (RHTN) reported inconsistent results, ultrasound RDN (uRDN) was …

The Microsoft Research Aurora Project: important findings on cuffless blood pressure measurement

R Mukkamala, SG Shroff, C Landry, KG Kyriakoulis… - …, 2023 - Am Heart Assoc
Conventional blood pressure (BP) measurement devices based on an inflatable cuff only
provide a narrow view of the continuous BP profile. Cuffless BP measuring technologies …